For research use only. Not for therapeutic Use.
DC-TEADin02（Cat No.:I042330）is a small molecule inhibitor designed to target the TEAD (TEA domain) transcription factors, which are key regulators in the Hippo signaling pathway. This pathway plays a crucial role in cell growth, proliferation, and apoptosis, and its dysregulation is often associated with cancer and other diseases. By inhibiting TEAD, DC-TEADin02 aims to disrupt the interaction between TEAD and its co-activators, reducing tumor growth and metastasis. Research is focused on evaluating its potential as a therapeutic agent for cancers and conditions involving aberrant cell growth. Further studies are necessary to confirm its clinical efficacy.
| CAS Number | 2380228-45-3 |
| Synonyms | N-[4-(naphthalen-2-ylmethyl)phenyl]ethenesulfonamide |
| Molecular Formula | C19H17NO2S |
| Purity | ≥95% |
| IUPAC Name | N-[4-(naphthalen-2-ylmethyl)phenyl]ethenesulfonamide |
| InChI | InChI=1S/C19H17NO2S/c1-2-23(21,22)20-19-11-8-15(9-12-19)13-16-7-10-17-5-3-4-6-18(17)14-16/h2-12,14,20H,1,13H2 |
| InChIKey | IUZGUIPYVGPQFT-UHFFFAOYSA-N |
| SMILES | C=CS(=O)(=O)NC1=CC=C(C=C1)CC2=CC3=CC=CC=C3C=C2 |
